Ophthalmic Product Development Insights
A look at ocular/nasal interactions and how they can affect our
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis
DEXTENZA successfully met primary endpoint for treatment of ocular itching associated with allergic conjunctivitis
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
The placid ocular surface is actually teeming with life that might
hold the secret to treating ophthalmic disease.
Allergic conjunctivitis is a common and potentially debilitating condition affecting
the conjunctiva, eyelids and cornea, and it is often associated with nonocular symptoms
and signs of rhinitis or sinusitis.
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
Clinical trial for the treatment of allergic rhinitis for 3E Therapeutics Corporation